Cargando…

Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome

A 58-year-old woman with a history of systemic lupus erythematosus (SLE) who was taking prednisolone and mycophenolate mofetil presented with gait disturbances that progressively worsened over a period of 3 months. Her blood test and cerebrospinal fluid (CSF) examination results did not indicate act...

Descripción completa

Detalles Bibliográficos
Autores principales: Akimoto, Takayoshi, Hara, Makoto, Hirose, Satoshi, Nakamichi, Kazuo, Nakajima, Hideto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443244/
https://www.ncbi.nlm.nih.gov/pubmed/37606392
http://dx.doi.org/10.3390/neurolint15030059
_version_ 1785093781839675392
author Akimoto, Takayoshi
Hara, Makoto
Hirose, Satoshi
Nakamichi, Kazuo
Nakajima, Hideto
author_facet Akimoto, Takayoshi
Hara, Makoto
Hirose, Satoshi
Nakamichi, Kazuo
Nakajima, Hideto
author_sort Akimoto, Takayoshi
collection PubMed
description A 58-year-old woman with a history of systemic lupus erythematosus (SLE) who was taking prednisolone and mycophenolate mofetil presented with gait disturbances that progressively worsened over a period of 3 months. Her blood test and cerebrospinal fluid (CSF) examination results did not indicate active SLE. Initial brain magnetic resonance imaging (MRI) revealed a small spotty lesion in the left cerebellar peduncle. The clinical course was consistent with rapidly progressive cerebellar syndrome (RPCS), which sometimes involves neuronal antibodies. The line blot assay detected anti-Yo antibodies, but no malignancy was found. Immunohistological techniques using rat brain sections yielded a negative result for anti-Yo antibodies. The second MRI revealed a focal lesion and surrounding spotty lesion in the left cerebellar peduncle, which was consistent with the punctate pattern observed in progressive multifocal leukoencephalopathy (PML). The CSF JCV-DNA test indicated the presence of cerebellar PML. Immunosuppressants were reduced, and mefloquine and mirtazapine were initiated. After approximately 2 years and 1 month, the CSF JCV-DNA results became negative. Cerebellar PML may exhibit a clinical course that is consistent with RPCS. The punctate pattern should be recognized as an early manifestation of PML. The CSF JCV-DNA copy number may serve as a useful indicator of PML stabilization.
format Online
Article
Text
id pubmed-10443244
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104432442023-08-23 Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome Akimoto, Takayoshi Hara, Makoto Hirose, Satoshi Nakamichi, Kazuo Nakajima, Hideto Neurol Int Case Report A 58-year-old woman with a history of systemic lupus erythematosus (SLE) who was taking prednisolone and mycophenolate mofetil presented with gait disturbances that progressively worsened over a period of 3 months. Her blood test and cerebrospinal fluid (CSF) examination results did not indicate active SLE. Initial brain magnetic resonance imaging (MRI) revealed a small spotty lesion in the left cerebellar peduncle. The clinical course was consistent with rapidly progressive cerebellar syndrome (RPCS), which sometimes involves neuronal antibodies. The line blot assay detected anti-Yo antibodies, but no malignancy was found. Immunohistological techniques using rat brain sections yielded a negative result for anti-Yo antibodies. The second MRI revealed a focal lesion and surrounding spotty lesion in the left cerebellar peduncle, which was consistent with the punctate pattern observed in progressive multifocal leukoencephalopathy (PML). The CSF JCV-DNA test indicated the presence of cerebellar PML. Immunosuppressants were reduced, and mefloquine and mirtazapine were initiated. After approximately 2 years and 1 month, the CSF JCV-DNA results became negative. Cerebellar PML may exhibit a clinical course that is consistent with RPCS. The punctate pattern should be recognized as an early manifestation of PML. The CSF JCV-DNA copy number may serve as a useful indicator of PML stabilization. MDPI 2023-07-26 /pmc/articles/PMC10443244/ /pubmed/37606392 http://dx.doi.org/10.3390/neurolint15030059 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Akimoto, Takayoshi
Hara, Makoto
Hirose, Satoshi
Nakamichi, Kazuo
Nakajima, Hideto
Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
title Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
title_full Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
title_fullStr Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
title_full_unstemmed Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
title_short Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome
title_sort cerebellar progressive multifocal leukoencephalopathy mimicking anti-yo-antibody-associated rapidly progressive cerebellar syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443244/
https://www.ncbi.nlm.nih.gov/pubmed/37606392
http://dx.doi.org/10.3390/neurolint15030059
work_keys_str_mv AT akimototakayoshi cerebellarprogressivemultifocalleukoencephalopathymimickingantiyoantibodyassociatedrapidlyprogressivecerebellarsyndrome
AT haramakoto cerebellarprogressivemultifocalleukoencephalopathymimickingantiyoantibodyassociatedrapidlyprogressivecerebellarsyndrome
AT hirosesatoshi cerebellarprogressivemultifocalleukoencephalopathymimickingantiyoantibodyassociatedrapidlyprogressivecerebellarsyndrome
AT nakamichikazuo cerebellarprogressivemultifocalleukoencephalopathymimickingantiyoantibodyassociatedrapidlyprogressivecerebellarsyndrome
AT nakajimahideto cerebellarprogressivemultifocalleukoencephalopathymimickingantiyoantibodyassociatedrapidlyprogressivecerebellarsyndrome